BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,860,426 | -31.0% | 41,352 | +1.0% | 0.01% | -40.0% |
| Q3 2022 | $2,697,000 | -8.1% | 40,927 | -29.6% | 0.02% | 0.0% |
| Q2 2022 | $2,936,000 | +27.0% | 58,132 | +121.3% | 0.02% | -6.2% |
| Q2 2021 | $2,311,000 | +21.4% | 26,268 | +34.2% | 0.02% | +14.3% |
| Q1 2021 | $1,903,000 | -85.9% | 19,575 | -83.7% | 0.01% | -87.6% |
| Q4 2020 | $13,470,000 | +727.9% | 120,104 | +584.4% | 0.11% | +707.1% |
| Q3 2020 | $1,627,000 | +525.8% | 17,550 | +294.0% | 0.01% | +100.0% |
| Q1 2020 | $260,000 | -74.8% | 4,454 | -65.4% | 0.01% | -65.0% |
| Q4 2019 | $1,032,000 | -53.3% | 12,882 | -45.1% | 0.02% | -67.2% |
| Q2 2019 | $2,212,000 | +37.3% | 23,450 | -26.3% | 0.06% | +52.5% |
| Q2 2017 | $1,611,000 | – | 31,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |